Literature DB >> 19968715

Binase cleaves cellular noncoding RNAs and affects coding mRNAs.

Vladimir A Mitkevich1, Nickolai A Tchurikov, Pavel V Zelenikhin, Irina Yu Petrushanko, Alexander A Makarov, Olga N Ilinskaya.   

Abstract

Bacterial RNases are promising tools for the development of anticancer drugs. Neoplastic transformation leads to enhanced accumulation of rRNA and tRNA, and altered expression of regulatory noncoding RNAs. Cleavage of RNA in cancer cells is the main reason for the cytotoxic effects of exogenic RNases. We have shown that binase, a cytotoxic ribonuclease from Bacillus intermedius, affects the total amount of intracellular RNA and the expression of proapoptotic and antiapoptotic mRNAs. For four cell lines, we visualized cellular RNA by fluorescence microscopy, and determined RNA levels, viability and apoptosis by flow cytometry. We found that the level of cellular RNA was decreased in cells that were sensitive to the cytotoxic effects of binase. The RNA level was lowered by 44% in HEK cells transfected with the hSK4 gene of the Ca(2+)-activated potassium channels (HEKhSK4) and by 20% in kit-transformed myeloid progenitor FDC-P1iR1171 cells. The most significant decrease in RNA levels was registered in the subpopulations of apoptotic cells. However, the binase-induced RNA decrease did not correlate with apoptosis. Kit-transformed cells with binase-induced RNA decrease retained viability if the interleukin-dependent proliferation pathway was activated. Using quantitative RT-PCR with RNA samples isolated from the binase-treated HEKhSK4 cells, we found that the amount of mRNA of the antiapoptotic bcl-2 gene in vivo was reduced about two-fold. In contrast, expression of the proapoptotic genes p53 and hSK4 was increased 1.5-fold and 4.3-fold, respectively. These results show that binase is a regulator of RNA-dependent processes of cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968715     DOI: 10.1111/j.1742-4658.2009.07471.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  13 in total

1.  Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo.

Authors:  Islam Saber Ead Mohamed; Aleksandra V Sen'kova; Oleg V Markov; Andrey V Markov; Innokenty A Savin; Marina A Zenkova; Nadezhda L Mironova
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

2.  Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.

Authors:  Nadezhda L Mironova; Irina Y Petrushanko; Olga A Patutina; Aexandra V Sen'kova; Olga V Simonenko; Vladimir A Mitkevich; Oleg V Markov; Marina A Zenkova; Alexander A Makarov
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

3.  MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

4.  Antiviral Activity of Binase against the Pandemic Influenza A (H1N1) Virus.

Authors:  R Shah Mahmud; O N Ilinskaya
Journal:  Acta Naturae       Date:  2013-10       Impact factor: 1.845

5.  Binase treatment increases interferon sensitivity and apoptosis in SiHa cervical carcinoma cells by downregulating E6 and E7 human papilloma virus oncoproteins.

Authors:  Vladimir A Mitkevich; Ksenia M Burnysheva; Irina Yu Petrushanko; Alexei A Adzhubei; Alexey A Schulga; Peter M Chumakov; Alexander A Makarov
Journal:  Oncotarget       Date:  2017-08-10

6.  Binase Immobilized on Halloysite Nanotubes Exerts Enhanced Cytotoxicity toward Human Colon Adenocarcinoma Cells.

Authors:  Vera Khodzhaeva; Anna Makeeva; Vera Ulyanova; Pavel Zelenikhin; Vladimir Evtugyn; Martin Hardt; Elvira Rozhina; Yuri Lvov; Rawil Fakhrullin; Olga Ilinskaya
Journal:  Front Pharmacol       Date:  2017-09-12       Impact factor: 5.810

Review 7.  Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.

Authors:  Nadezhda Mironova; Valentin Vlassov
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

8.  The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  Oncotarget       Date:  2017-08-12

9.  Antitumour Activity of the Ribonuclease Binase from Bacillus pumilus in the RLS40 Tumour Model Is Associated with the Reorganisation of the miRNA Network and Reversion of Cancer-Related Cascades to Normal Functioning.

Authors:  Islam Saber Ead Mohamed; Aleksandra V Sen'kova; Alsu I Nadyrova; Innokenty A Savin; Andrey V Markov; Vladimir A Mitkevich; Aleksander A Makarov; Olga N Ilinskaya; Nadezhda L Mironova; Marina A Zenkova
Journal:  Biomolecules       Date:  2020-11-02

10.  Supramolecular Organization As a Factor of Ribonuclease Cytotoxicity.

Authors:  E V Dudkina; V V Ulyanova; O N Ilinskaya
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.